Novo Nordisk’s Sustainable Business Approach in China Cited by Michael Porter

Primary tabs

Novo Nordisk
Keywords: Corporate Social Responsibility | Michael Porter | Novo Nordisk | Positive Change | Reports | Social Development | Socially Responsible Investing | Sustainability Professionals | Sustainable Enterprises | Sustainable Investment | Sustainable Solutions

Novo Nordisk’s Sustainable Business Approach in China Cited by Michael Porter

Report on shared value released: ‘Competing by Saving Lives: How Pharmaceutical and Medical Device Companies Create Shared Value in Global Health’
tweet me:
Novo Nordisk's Triple Bottom Line receives the attention of Harvard's Michael Porter http://3bl.me/eakwze #sustainability #esg #csr
Press Release
Wednesday, March 14, 2012 - 12:15pm

(3BL Media) March 14, 2012 - Novo Nordisk's Triple Bottom Line business approach has caught the attention of world-renowned business strategist, Michael Porter of Harvard Business School. Last year, Novo Nordisk published 'The Blueprint for Change: Changing diabetes in China' on how strengthening of the healthcare system and establishing local stakeholder relations are key elements of Novo Nordisk's long-term business strategy for China.

Read the full story

 


Novo Nordisk is a focused healthcare company.

Novo Nordisk is a healthcare company and a world leader in diabetes care.

In addition, Novo Nordisk has a leading position within areas such as haemostasis management, growth hormone therapy and hormone replacement therapy. Novo Nordisk manufactures and markets pharmaceutical products and services that make a significant difference to patients, the medical prsion and society.

www.novonordisk.com